Andreas Seidl
Direttore Tecnico/Scientifico/R&S presso FORMYCON AG
Profilo
Andreas Seidl is currently the Chief Operating Officer at LEUKOCARE AG and the Chief Scientific Officer at Formycon AG.
He holds a doctorate degree from Universität Konstanz.
Posizioni attive di Andreas Seidl
| Società | Posizione | Inizio |
|---|---|---|
| FORMYCON AG | Direttore Tecnico/Scientifico/R&S | 01/07/2022 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Direttore operativo | 01/04/2019 |
Formazione di Andreas Seidl
| Universität Konstanz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Aziende private | 1 |
|---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
- Borsa valori
- Insiders
- Andreas Seidl
